Wary Of Risks, FDA Mulls Ban On Common Soap Ingredient

Law360, New York (December 16, 2013, 4:20 PM EST) -- Citing risks to human hormones, the U.S. Food and Drug Administration on Monday said it will block sales of antibacterial hand soaps with controversial ingredient triclosan unless manufacturers prove that the ubiquitous products are more effective than traditional soap and safe for long-term use.

FDA’s action, which prompted an angry backlash from trade groups, followed years of debate over whether triclosan may significantly damage the endocrine system and promote resistance to antibiotics.

To continue promoting antibacterial attributes, soap manufacturers will have to conduct clinical trials proving...
To view the full article, register now.